Volcano Corporation Presentation at JMP Conference to be Webcast

Tuesday, May 20, 2008 General News J E 4
SAN DIEGO, May 19 Volcano Corporation(Nasdaq: VOLC), a provider of intravascular ultrasound (IVUS), functionalmeasurement (FM) and Optical Coherence Tomography (OCT) products designed toenhance the diagnosis and treatment of coronary and peripheral vasculardisease, said today that it will be participating in the Seventh Annual JMPSecurities Research Conference on Tuesday, May 20.

The presentation by Scott Huennekens, president and chief executiveofficer, will begin at 11:30 a.m., Pacific Daylight Time (2:30 p.m., EasternDaylight Time).

The presentation will be available through the conference website at or via the company's website at

Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devicesdesigned to facilitate endovascular procedures, enhance the diagnosis ofvascular and structural heart disease and guide optimal therapies. Thecompany's intravascular ultrasound (IVUS) product line includes ultrasoundconsoles that can be integrated directly into virtually any modern cath lab.Volcano IVUS offers unique features, including both single-use phased arrayand rotational IVUS imaging catheters, and advanced functionality options,such as VH(TM) tissue characterization and ChromaFlo(R). Volcano also providesfunctional measurement (FM) consoles and single-use pressure and flow guidewires and is developing a line of ultra-high resolution Optical CoherenceTomography (OCT) systems and catheters. Currently, more than 3,300 VolcanoIVUS and FM systems are installed worldwide, with approximately half of itsrevenues coming from outside the United States. For more information, visitthe company's website at

SOURCE Volcano Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Ventas Declares Regular Quarterly Dividend of $0.5...
UPDATE: Infant Primates Given Vaccines on U.S. Chi...